Press releases

VALBIOTIS expands its innovation capacity with its Preclinical Research platform

September 18th 2018

VALBIOTIS expands its innovation capacity with its new Discovery and Preclinical Research platform.

Read more

Positive results from Phase I/II clinical study on LpD64

September 11th 2018

VALBIOTIS announces positive results from its Phase I/II clinical study conducted on LpD64 in obese subjects

Read more

Appointment of Pascal SIRVENT to the Board of Directors of VALBIOTIS

August 30th 2018

VALBIOTIS strengthens its Board of Directors and announces the appointment of Pascal SIRVENT.

Read more

Half-year report of the liquidity contract – July 2018

July 17th 2018

VALBIOTIS presents the half-year report of its liquidity contract (in French)

Read more